<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Chondroitin sulfate</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Chondroitin_sulfate">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Chondroitin sulfate</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Chondroitin sulfate</b> is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (<a href="N-Acetylgalactosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylgalactosamine" title="N-Acetylgalactosamine">N-acetylgalactosamine</a> and <a href="Glucuronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucuronic_acid" title="Glucuronic acid">glucuronic acid</a>). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities.  Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Along with <a href="Glucosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucosamine" title="Glucosamine">glucosamine</a>, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.</p>

<div class="thumb tright"><div class="thumbinner" style="width:242px"><img src="../I/m/Chondroitin_Sulfate_Structure_NTP.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chondroitin_Sulfate_Structure_NTP.png" data-file-width="977" data-file-height="422" data-file-type="bitmap" height="104" width="240"><div class="thumbcaption" style="text-align: left">Chemical structure of one unit in a chondroitin sulfate chain. Chondroitin-4-sulfate: R<sub>1</sub> = H; R<sub>2</sub> = SO<sub>3</sub>H; R<sub>3</sub> = H. Chondroitin-6-sulfate: R<sub>1</sub> = SO<sub>3</sub>H; R<sub>2</sub>, R<sub>3</sub> = H.</div></div></div>

</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    

<p>Chondroitin is used in dietary supplements as an alternative medicine to treat osteoarthritis and also approved and regulated as a symptomatic slow-acting drug for this disease (SYSADOA) in Europe and some other countries.<span class="mw-ref" id="cite_ref-Cochrane2015_2-0"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span>  It is commonly sold together with <a href="Glucosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucosamine" title="Glucosamine">glucosamine</a>.<span class="mw-ref" id="cite_ref-Cochrane2015_2-1"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span>  A 2015 Cochrane review of clinical trials found that most were of low quality, but that there was some evidence of short-term improvement in pain and few side effects;  it does not appear to improve or maintain the health of affected joints.<span class="mw-ref" id="cite_ref-Cochrane2015_2-2"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Chondroitin, along with commonly used glucosamine, should not be used to treat people who have symptomatic osteoarthritis of the knee as evidence shows that these treatments fail to provide relief for that condition.<span class="mw-ref" id="cite_ref-AAOSfive_3-0"><a href="#cite_note-AAOSfive-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Clinical studies have not identified any significant side effects or overdoses of chondroitin sulfate, which suggest its long-term safety.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In 2003 the Task Force of the European League Against Rheumatism (EULAR) committee ranked the level of toxicity of chondroitin sulfate 6 in a 0-100 scale.<span class="mw-ref" id="cite_ref-Jordan2003_5-0"><a href="#cite_note-Jordan2003-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>Chondroitin sulfate is not metabolized by cytochrome P450.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanisms_of_action">Mechanisms of action</h3></summary>
    

<p>The effect of chondroitin sulfate in people with osteoarthritis is likely the result of a number of reactions including its anti-inflammatory activity, the stimulation of the synthesis of proteoglycans and hyaluronic acid, and the decrease in catabolic activity of chondrocytes, inhibiting the synthesis of proteolytic enzymes, nitric oxide, and other substances that contribute to damage the cartilage matrix and cause death of articular chondrocytes. A recent review summarizes data from relevant reports describing the biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bioavailability_and_pharmacokinetics">Bioavailability and pharmacokinetics</h3></summary>
    
<p>Pharmacokinetic studies performed on humans and experimental animals after oral administration of chondroitin sulfate revealed that it can be absorbed orally. Chondroitin sulfate shows first-order kinetics up to single doses of 3,000<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Multiple doses of 800<span>&nbsp;</span>mg in people with osteoarthritis do not alter the kinetics of chondroitin sulfate. The bioavailability of chondroitin sulfate ranges from 15% to 24% of the orally administered dose. More particularly, on the articular tissue, Ronca et al.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> reported that chondroitin sulfate is not rapidly absorbed in the gastro-intestinal tract and a high content of labeled chondroitin sulfate is found in the synovial fluid and cartilage.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Physical_and_chemical_properties">Physical and chemical properties</h2></summary>
    
<p>Chondroitin sulfate chains are unbranched polysaccharides of variable length containing two alternating monosaccharides: <a href="Glucuronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucuronic_acid" title="Glucuronic acid">D-glucuronic acid</a> (GlcA) and <a href="N-Acetylgalactosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylgalactosamine" title="N-Acetylgalactosamine">N-acetyl-D-galactosamine</a> (GalNAc).  Some GlcA residues are epimerized into <a href="Iduronic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iduronic_acid" title="Iduronic acid">L-iduronic acid</a> (IdoA); the resulting disaccharide is then referred to as <a href="Dermatan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dermatan_sulfate" title="Dermatan sulfate">dermatan sulfate</a>.</p>

<p>Chondroitin sulfate chains are linked to hydroxyl groups on <a href="Serine.htm" tppabs="https://ptable.com/wiki/compounds/A/Serine" title="Serine">serine</a> residues of certain proteins. Exactly how proteins are selected for attachment of glycosaminoglycans is not understood.  Glycosylated serines are often followed by a glycine and have neighboring acidic residues, but this motif does not always predict glycosylation.</p>

<p>Attachment of the GAG chain begins with four monosaccharides in a fixed pattern: <a href="Xylose.htm" tppabs="https://ptable.com/wiki/compounds/A/Xylose" title="Xylose">Xyl</a> - <a href="Galactose.htm" tppabs="https://ptable.com/wiki/compounds/A/Galactose" title="Galactose">Gal</a> - Gal - GlcA.  Each sugar is attached by a specific enzyme, allowing for multiple levels of control over GAG synthesis. Xylose begins to be attached to proteins in the endoplasmic reticulum, while the rest of the sugars are attached in the Golgi apparatus.<span class="mw-ref" id="cite_ref-Silbert_2002_13-0"><a href="#cite_note-Silbert_2002-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Chondroitin sulfate was originally isolated well before the structure was characterised, leading to changes in terminology with time.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span>  Early researchers identified different fractions of the substance with letters.</p>

<table class="wikitable">
<tbody><tr><td><b>Letter identification</b></td><td><b>Site of sulfation</b></td><td><b>Systematic name</b></td></tr>
 <tr> 
 <td><i>Chondroitin sulfate A</i></td><td>carbon 4 of the N-acetylgalactosamine (GalNAc) sugar</td><td>chondroitin-4-sulfate</td></tr>
 <tr> 
 <td><i>Chondroitin sulfate C</i></td><td>carbon 6 of the GalNAc sugar</td><td>chondroitin-6-sulfate</td></tr>
 <tr> 
 <td><i>Chondroitin sulfate D</i></td><td>carbon 2 of the glucuronic acid and 6 of the GalNAc sugar</td><td>chondroitin-2,6-sulfate</td></tr>
 <tr> 
 <td><i>Chondroitin sulfate E</i></td><td>carbons 4 and 6 of the GalNAc sugar</td><td>chondroitin-4,6-sulfate</td></tr>
</tbody></table>

<p>"Chondroitin sulfate B" is an old name for <a href="Dermatan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dermatan_sulfate" title="Dermatan sulfate">dermatan sulfate</a>, and it is no longer classified as a form of chondroitin sulfate.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p><i>Chondroitin</i>, without the "sulfate", has been used to describe a fraction with little or no sulfation.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span>  However, this distinction is not used by all.</p>

<p>Although the name "chondroitin sulfate" suggests a salt with a sulfate counter-anion, this is not the case, as sulfate is covalently bonded to the sugar. Rather, since the molecule has multiple negative charges at physiological pH, a cation is present in salts of chondroitin sulfate.  Commercial preparations of chondroitin sulfate typically are the sodium salt. Barnhill et al. have suggested that all such preparations of chondroitin sulfate be referred to as "sodium chondroitin" regardless of their sulfation status.<span class="mw-ref" id="cite_ref-Barnhill_17-0"><a href="#cite_note-Barnhill-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>In 2008 the U.S. Food and Drug Administration (FDA) identified "oversulfated chondroitin sulfate" as a contaminant in <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a> originating from China.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Clinical_trials_for_osteoarthritis">Clinical trials for osteoarthritis</h3></summary>
    


<p>In 2004, a petition was submitted to the FDA that a dietary supplement of chondroitin sulfate be labeled as reducing the risk of osteoarthritis, cartilage deterioration, and osteoarthritis-related joint pain, tenderness, and swelling.  The FDA denied the request, stating that experiments conducted by the company did not sufficiently demonstrate the effectiveness of the claim.  Among other comments, the FDA noted the poor experimental design of some trials.<span class="mw-ref" id="cite_ref-FDACS_21-0"><a href="#cite_note-FDACS-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>In 2007, Reichenbach et al. used explicit methods to conduct and report a systematic review of 20 trials and concluded "large-scale, methodologically sound trials indicate that the symptomatic benefit of chondroitin is minimal or nonexistent. Use of chondroitin in routine clinical practice should therefore be discouraged."
In contrast, and also in 2007, Bruyere et al. concluded that "there is compelling evidence that glucosamine sulfate and chondroitin sulfate may interfere with progression of OA."</p>

<p>As of 2015 the largest trial conducted with the product was the Glucosamine and Chondroitin Arthritis Intervention Trial (GAIT), a double-blind, randomized, multicenter clinical trial sponsored by the US National Institutes of Health in 1583 people with knee osteoarthritis, which was published in the New England Journal of Medicine in 2006.<span class="mw-ref" id="cite_ref-Cochrane2015_2-3"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Clegg_DO_2006_22-0"><a href="#cite_note-Clegg_DO_2006-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Subjects were randomly assigned to one of five orally administered treatments: two 250<span>&nbsp;</span>mg capsules of glucosamine hydrochloride three times daily, two 200<span>&nbsp;</span>mg capsules of chondroitin sulphate three times daily, two capsules of 250<span>&nbsp;</span>mg of glucosamine hydrochloride plus 200<span>&nbsp;</span>mg of chondroitin sulphate three times daily, 200<span>&nbsp;</span>mg of <a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">celecoxib</a> daily, or placebo. Treatment was administered for 24 weeks. It showed no difference from placebo.<span class="mw-ref" id="cite_ref-Cochrane2015_2-4"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Sawitzke A, et al. 2010 evaluated the efficacy and safety of glucosamine and chondroitin sulfate, alone or in combination, as well as celecoxib and placebo on painful knee osteoarthritis over 2 years as a continuation of the GAIT trial. This was a 24-month, double-blind, placebo-controlled study, enrolling 662 people with knee osteoarthritis who satisfied radiographic criteria (Kellgren/Lawrence grade 2 or 3 changes and baseline joint space width of at least 2<span>&nbsp;</span>mm). This subset continued to receive their randomized treatment (glucosamine 500<span>&nbsp;</span>mg three times daily, chondroitin sulfate 400<span>&nbsp;</span>mg three times daily, the combination of glucosamine and chondroitin sulfate, celecoxib 200<span>&nbsp;</span>mg daily, or placebo) over 24 months. The primary outcome was a 20% reduction in pain over 24 months as measured by the Western Ontario and McMaster University Osteoarthritis Index (WOMAC). Secondary outcomes included an Outcome Measures in Rheumatology/Osteoarthritis Research Society International response and change from baseline in WOMAC pain and function.<span class="mw-ref" id="cite_ref-Cochrane2015_2-5"><a href="#cite_note-Cochrane2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Sawitzke2010_23-0"><a href="#cite_note-Sawitzke2010-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Over 2 years, none of the treatments (not even the positive control celecoxib) achieved a clinically important difference in WOMAC pain or function as compared with placebo. Adverse reactions were similar among treatment groups and serious adverse events were rare for all treatments.<span class="mw-ref" id="cite_ref-Sawitzke2010_23-1"><a href="#cite_note-Sawitzke2010-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Manufacture">Manufacture</h3></summary>
    
<p>Most chondroitin appears to be made from extracts of cartilaginous cow and pig tissues (cow trachea and pig ear and nose), but other sources such as shark, fish, and bird cartilage are also used. Since chondroitin is not a uniform substance, and is naturally present in a wide variety of forms, the precise composition of each supplement will vary.<span class="mw-ref" id="cite_ref-Barnhill_17-1"><a href="#cite_note-Barnhill-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> In fact, although many food supplement companies produce their products in compliance with human food processing Good Manufacturing Practice (GMP), most of them do not produce their products in compliance with the GMP regulations for pharmaceuticals, resulting in products not meeting pharmaceutical requirements.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<p>While it is a prescription or over-the-counter drug in 22 countries, chondroitin is regulated in the U.S. as a dietary supplement<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> by the Food and Drug Administration. In Europe, chondroitin sulfate formulations are approved as drugs with evidenced efficacy and safety demonstrated by clinical trials in people with osteoarthritis.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Adebowale et al. reported in 2000 that of 32 chondroitin supplements they analysed, only 5 were labeled correctly, and more than half contained less than 40% of the labeled amount.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> With the introduction of GMP regulations for dietary supplements in 2008, chondroitin sulfate preparations are subject in the US to mandatory labeling standards as well as testing requirements for identity, purity, strength, and composition. United States Pharmacopoeia (USP) testing standards for the identification and quantification of chondroitin are well-established.</p>

<p>There are no FDA regulations on chondroitin sulfate as a food additive, as it is recognized by the FDA as a component of food and is "generally recognized as safe".<span class="mw-ref" id="cite_ref-FDACS_21-1"><a href="#cite_note-FDACS-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> However, a proposed application of chondroitin sulfate dietary supplement as a means of preventing joint degeneration was highly scrutinized by the FDA, who stated:</p>

<style data-mw-deduplicate="TemplateStyles:r960796168">.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}</style><blockquote class="templatequote"><p>" For conventional foods, this evaluation involves considering whether the ingredient that is the source of the substance is generally recognized as safe (GRAS), approved as a food additive, or authorized by a prior sanction issued by FDA (see 21 CFR 101.70(f)). Dietary ingredients in dietary supplements, however, are not subject to the food additive provisions of the act (see section 201(s)(6) of the Act (21 U.S.C. § 321(s)(6)). Rather, they are subject to the adulteration provisions in section 402 of the Act (21 U.S.C. 342) and, if applicable, the new dietary ingredient provisions in section 413 of the Act (21 U.S.C. 350b), which pertain to dietary ingredients that were not marketed in the United States before October 15, 1994."</p><div class="templatequotecite">—<span> </span><cite>Letter Regarding the Relationship Between the Consumption of Glucosamine and/or Chondroitin Sulfate and a Reduced Risk of: Osteoarthritis; Osteoarthritis-related Joint Pain, Joint Tenderness, and Joint Swelling; Joint Degeneration; and Cartilage Deterioration</cite></div></blockquote>

<p>In the same letter, the FDA found that studies performed on the dietary supplement form of chondroitin sulfate were insufficient to substantiate claims that it is efficacious in the prevention of joint deterioration, and denied the request to be allowed to label the supplement as such.  They further denied the request to market it as safe, given that no human clinical trials were done, citing that animal studies are not sufficient for the approval of a dietary supplement.<span class="mw-ref" id="cite_ref-FDACS_21-2"><a href="#cite_note-FDACS-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Veterinary_use">Veterinary use</h2></summary>
    
<p>Chondroitin and glucosamine are also used in veterinary medicine for osteoarthritis.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Proteoglycan</li>
<li><a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">Hepar<i>in</i> sulfate</a> - a glycosaminoglycan of major pharmaceutical importance for many decades</li>
<li><a href="Heparan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparan_sulfate" title="Heparan sulfate">Hepar<i>an</i> sulfate</a> - a glycosaminoglycan component of proteoglycans in a wide range of vertebrate &amp; invertebrate life</li>
<li><a href="Methylsulfonylmethane.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylsulfonylmethane" title="Methylsulfonylmethane">Methylsulfonylmethane</a></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFBaeurleKiselevMakarovaNogovitsin2009" class="citation journal cs1">Baeurle SA, Kiselev MG, Makarova ES, Nogovitsin EA (2009). "Effect of the counterion behavior on the frictional–compressive properties of chondroitin sulfate solutions". <i>Polymer</i>. <b>50</b> (7): 1805–1813. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.polymer.2009.01.066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.polymer.2009.01.066'" tppabs="https://doi.org/10.1016%2Fj.polymer.2009.01.066" class="external text external">10.1016/j.polymer.2009.01.066</a>.</cite></span></li><li id="cite_note-Cochrane2015-2"> <span id="mw-reference-text-cite_note-Cochrane2015-2" class="mw-reference-text"><cite id="CITEREFSinghNoorbaloochiMacDonaldMaxwell2015" class="citation journal cs1">Singh, JA; Noorbaloochi, S; MacDonald, R; Maxwell, LJ (28 January 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293" class="external text external">"Chondroitin for osteoarthritis"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD005614. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD005614.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD005614.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD005614.pub2" class="external text external">10.1002/14651858.CD005614.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881293" class="external text external">4881293</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25629804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25629804'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25629804" class="external text external">25629804</a>.</cite></span></li><li id="cite_note-AAOSfive-3"> <span id="mw-reference-text-cite_note-AAOSfive-3" class="mw-reference-text"><cite id="CITEREFAmerican_Academy_of_Orthopaedic_Surgeons2013" class="citation cs2">American Academy of Orthopaedic Surgeons (February 2013), <a href="javascript:if(confirm('http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-orthopaedic-surgeons/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-orthopaedic-surgeons/'" tppabs="http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-orthopaedic-surgeons/" class="external text external">"Five Things Physicians and Patients Should Question"</a>, <i>Choosing Wisely: an initiative of the ABIM Foundation</i>, American Academy of Orthopaedic Surgeons<span class="reference-accessdate">, retrieved <span class="nowrap">19 May</span> 2013</span></cite>, which cites
<ul><li><cite id="CITEREFJevsevarBrown,_GAJones,_DLMatzkin,_EG2013" class="citation journal cs1">Jevsevar, DS; Brown, GA; Jones, DL; Matzkin, EG; Manner, PA; Mooar, P; Schousboe, JT; Stovitz, S; Sanders, JO; Bozic, KJ; Goldberg, MJ; Martin WR, 3rd; Cummins, DS; Donnelly, P; Woznica, A; Gross, L; American Academy of Orthopaedic Surgeons (Oct 16, 2013). "The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition". <i>The Journal of Bone and Joint Surgery. American Volume</i>. <b>95</b> (20): 1885–6. doi:<a href="javascript:if(confirm('https://doi.org/10.2106%2F00004623-201310160-00010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2106%2F00004623-201310160-00010'" tppabs="https://doi.org/10.2106%2F00004623-201310160-00010" class="external text external">10.2106/00004623-201310160-00010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24288804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24288804'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24288804" class="external text external">24288804</a>.</cite></li>
<li><cite id="CITEREFCleggReda,_Domenic_J.Harris,_Crystal_L.Klein,_Marguerite_A.2006" class="citation journal cs1">Clegg, Daniel O.; Reda, Domenic J.; Harris, Crystal L.; Klein, Marguerite A.; O'Dell, James R.; Hooper, Michele M.; Bradley, John D.; Bingham, Clifton O.; Weisman, Michael H.; Jackson, Christopher G.; Lane, Nancy E.; Cush, John J.; Moreland, Larry W.; Schumacher, H. Ralph; Oddis, Chester V.; Wolfe, Frederick; Molitor, Jerry A.; Yocum, David E.; Schnitzer, Thomas J.; Furst, Daniel E.; Sawitzke, Allen D.; Shi, Helen; Brandt, Kenneth D.; Moskowitz, Roland W.; Williams, H. James (23 February 2006). <a href="javascript:if(confirm('http://www.escholarship.org/uc/item/7zw280cw  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.escholarship.org/uc/item/7zw280cw'" tppabs="http://www.escholarship.org/uc/item/7zw280cw" class="external text external">"Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis"</a>. <i>New England Journal of Medicine</i>. <b>354</b> (8): 795–808. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa052771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa052771'" tppabs="https://doi.org/10.1056%2FNEJMoa052771" class="external text external">10.1056/NEJMoa052771</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16495392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16495392'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16495392" class="external text external">16495392</a>.</cite></li>
<li><cite id="CITEREFRichmondHunter,_DIrrgang,_JJones,_MH2009" class="citation journal cs1">Richmond, J; Hunter, D; Irrgang, J; Jones, MH; Levy, B; Marx, R; Snyder-Mackler, L; Watters WC, 3rd; Haralson RH, 3rd; Turkelson, CM; Wies, JL; Boyer, KM; Anderson, S; St Andre, J; Sluka, P; McGowan, R; American Academy of Orthopaedic Surgeons (Sep 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838" class="external text external">"Treatment of osteoarthritis of the knee (nonarthroplasty)"</a>. <i>The Journal of the American Academy of Orthopaedic Surgeons</i>. <b>17</b> (9): 591–600. doi:<a href="javascript:if(confirm('https://doi.org/10.5435%2F00124635-200909000-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5435%2F00124635-200909000-00006'" tppabs="https://doi.org/10.5435%2F00124635-200909000-00006" class="external text external">10.5435/00124635-200909000-00006</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170838" class="external text external">3170838</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19726743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19726743'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19726743" class="external text external">19726743</a>.</cite></li></ul></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text">13.	Hathcock JN, Shao a. Risk assessment for glucosamine and chondroitin sulfate. Regulatory Toxicology and Pharmacology, 2007; 47: 78-83</span></li><li id="cite_note-Jordan2003-5"> <span id="mw-reference-text-cite_note-Jordan2003-5" class="mw-reference-text"><cite id="CITEREFJordan_KMRecommendations_Arden_NK._EULAR2003" class="citation journal cs1">Jordan KM; Recommendations Arden NK. EULAR (2003). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382" class="external text external">"an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)"</a>. <i>Ann Rheum Dis</i>. <b>62</b> (12): 1145–1155. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fard.2003.011742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fard.2003.011742'" tppabs="https://doi.org/10.1136%2Fard.2003.011742" class="external text external">10.1136/ard.2003.011742</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754382" class="external text external">1754382</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14644851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14644851'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14644851" class="external text external">14644851</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text">Andermann G, Dietz M. The influence of the route of administration on the bioavailability of an endogenous macromolecule: chondroitin sulfate (CSA). Eur J Drug Metab Pharmacokinet 1982;7:11–6</span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFMonfortPelletierGarcia-GiraltMartel-Pelletier2008" class="citation journal cs1">Monfort, J; Pelletier, JP; Garcia-Giralt, N; Martel-Pelletier, J (June 2008). "Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues". <i>Annals of the Rheumatic Diseases</i>. <b>67</b> (6): 735–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fard.2006.068882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fard.2006.068882'" tppabs="https://doi.org/10.1136%2Fard.2006.068882" class="external text external">10.1136/ard.2006.068882</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17644553  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17644553'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17644553" class="external text external">17644553</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFContePalmieriSegniniRonca1991" class="citation journal cs1">Conte, A; Palmieri, L; Segnini, D; Ronca, G (1991). "Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat". <i>Drugs Exp Clin Res</i>. <b>17</b> (1): 27–33. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1914833  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1914833'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1914833" class="external text external">1914833</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFContede_BernardiPalmieriLualdi1991" class="citation journal cs1">Conte, A; de Bernardi, M; Palmieri, L; Lualdi, P; Mautone, G; Ronca, G (1991). "Metabolic fate of exogenous chondroitin sulfate in man". <i>Arzneimittelforschung</i>. <b>41</b> (7): 768–72. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1772467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1772467'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1772467" class="external text external">1772467</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFConteVolpiPalmieriBahous1995" class="citation journal cs1">Conte, A; Volpi, N; Palmieri, L; Bahous, I; Ronca, G (1995). "Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate". <i>Arzneimittelforschung</i>. <b>45</b> (8): 918–25. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7575762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7575762'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7575762" class="external text external">7575762</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text">Palmieri L, Conte A, Giovannini L, Lualdi P, Ronca G. Metabolic fate of exogenous chondroitin sulfate in the experimental animal" <i>Arzneimittelforschung</i> 1990;40:319-23.</span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text">Ronca F, Palmieri L, Panicucci P, Ronca G. "Anti-inflammatory activity of chondroitin sulfate" <i>Osteoarthritis and Cartilage</i> 1998;6 Suppl A:14-21.</span></li><li id="cite_note-Silbert_2002-13"> <span id="mw-reference-text-cite_note-Silbert_2002-13" class="mw-reference-text"><cite id="CITEREFSilbertSugumaran2002" class="citation journal cs1">Silbert JE, Sugumaran G (2002). "Biosynthesis of chondroitin/dermatan sulfate". <i>IUBMB Life</i>. <b>54</b> (4): 177–86. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F15216540214923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F15216540214923'" tppabs="https://doi.org/10.1080%2F15216540214923" class="external text external">10.1080/15216540214923</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12512856  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12512856'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12512856" class="external text external">12512856</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFP._A._LeveneF._B._La_Forge1913" class="citation journal cs1">P. A. Levene; F. B. La Forge (1913). "On Chondroitin Sulphuric Acid". <i>J. Biol. Chem</i>. <b>15</b>: 69–79.</cite> <a href="javascript:if(confirm('http://www.jbc.org/cgi/reprint/15/1/69  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jbc.org/cgi/reprint/15/1/69'" tppabs="http://www.jbc.org/cgi/reprint/15/1/69" class="external text external">Free PDF online</a></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><a href="javascript:if(confirm('https://meshb.nlm.nih.gov/record/ui?name=Chondroitin%20sulfates  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://meshb.nlm.nih.gov/record/ui?name=Chondroitin%20sulfates'" tppabs="https://meshb.nlm.nih.gov/record/ui?name=Chondroitin%20sulfates" class="external text external">Chondroitin+sulfates</a><span> at the US National Library of Medicine </span>Medical Subject Headings<span> (MeSH)</span></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFDavidsonMeyer1954" class="citation journal cs1">Davidson EA, Meyer K (1954). "Chondroitin, a new mucopolysaccharide". <i>J Biol Chem</i>. <b>211</b> (2): 605–11. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13221568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13221568'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13221568" class="external text external">13221568</a>.</cite> <a href="javascript:if(confirm('http://www.jbc.org/cgi/reprint/211/2/605  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jbc.org/cgi/reprint/211/2/605'" tppabs="http://www.jbc.org/cgi/reprint/211/2/605" class="external text external">Free PDF online</a></span></li><li id="cite_note-Barnhill-17"> <span id="mw-reference-text-cite_note-Barnhill-17" class="mw-reference-text"><cite id="CITEREFBarnhillFyeWilliamsReda2006" class="citation journal cs1">Barnhill JG, Fye CL, Williams DW, Reda DJ, Harris CL, Clegg DO (2006). "Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial". <i>Journal of the American Pharmacists Association</i>. <b>46</b> (1): 14–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1331%2F154434506775268616  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1331%2F154434506775268616'" tppabs="https://doi.org/10.1331%2F154434506775268616" class="external text external">10.1331/154434506775268616</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16529337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16529337'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16529337" class="external text external">16529337</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFZawisza2008" class="citation web cs1">Zawisza, Julie (2008-03-19). <a href="javascript:if(confirm('https://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM169335.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM169335.pdf'" tppabs="https://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM169335.pdf" class="external text external">"FDA Media Briefing on Heparin"</a> <span class="cs1-format">(PDF)</span>. U.S. Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-04-23</span></span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFGuerriniBeccatiShriverNaggi2008" class="citation journal cs1">Guerrini, M; Beccati, D; Shriver, Z; Naggi, A; Viswanathan, K; Bisio, A; Capila, I; Lansing, JC; Guglieri, S; Fraser, B; Al-Hakim, A; Gunay, NS; Zhang, Z; Robinson, L; Buhse, L; Nasr, M; Woodcock, J; Langer, R; Venkataraman, G; Linhardt, RJ; Casu, B; Torri, G; Sasisekharan, R (June 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566" class="external text external">"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events"</a>. <i>Nature Biotechnology</i>. <b>26</b> (6): 669–75. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnbt1407  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnbt1407'" tppabs="https://doi.org/10.1038%2Fnbt1407" class="external text external">10.1038/nbt1407</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491566" class="external text external">3491566</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18437154  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18437154'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18437154" class="external text external">18437154</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFKishimotoViswanathanGangulyElankumaran2008" class="citation journal cs1">Kishimoto, TK; Viswanathan, K; Ganguly, T; Elankumaran, S; Smith, S; Pelzer, K; Lansing, JC; Sriranganathan, N; Zhao, G; Galcheva-Gargova, Z; Al-Hakim, A; Bailey, GS; Fraser, B; Roy, S; Rogers-Cotrone, T; Buhse, L; Whary, M; Fox, J; Nasr, M; Dal Pan, GJ; Shriver, Z; Langer, RS; Venkataraman, G; Austen, KF; Woodcock, J; Sasisekharan, R (5 June 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681" class="external text external">"Contaminated heparin associated with adverse clinical events and activation of the contact system"</a>. <i>The New England Journal of Medicine</i>. <b>358</b> (23): 2457–67. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa0803200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa0803200'" tppabs="https://doi.org/10.1056%2FNEJMoa0803200" class="external text external">10.1056/NEJMoa0803200</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778681" class="external text external">3778681</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18434646  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18434646'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18434646" class="external text external">18434646</a>.</cite></span></li><li id="cite_note-FDACS-21"> <span id="mw-reference-text-cite_note-FDACS-21" class="mw-reference-text">Letter Regarding the Relationship Between the Consumption of Glucosamine and/or Chondroitin Sulfate and a Reduced Risk of: Osteoarthritis; Osteoarthritis-related Joint Pain, Joint Tenderness, and Joint Swelling; Joint Degeneration; and Cartilage Deterioration(Docket No. 2004P-0059). Addressed to John W. Emford, Esq. William K. Hubbard. Oct. 7, 2004. &lt;<a href="javascript:if(confirm('https://www.fda.gov/food/ingredientspackaginglabeling/labelingnutrition/ucm073400.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/food/ingredientspackaginglabeling/labelingnutrition/ucm073400.htm'" tppabs="https://www.fda.gov/food/ingredientspackaginglabeling/labelingnutrition/ucm073400.htm" class="external free external">https://www.fda.gov/food/ingredientspackaginglabeling/labelingnutrition/ucm073400.htm</a>&gt;</span></li><li id="cite_note-Clegg_DO_2006-22"> <span id="mw-reference-text-cite_note-Clegg_DO_2006-22" class="mw-reference-text"><cite id="CITEREFClegg2006" class="citation journal cs1">Clegg, DO;  et al. (2006). <a href="javascript:if(confirm('http://www.escholarship.org/uc/item/7zw280cw  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.escholarship.org/uc/item/7zw280cw'" tppabs="http://www.escholarship.org/uc/item/7zw280cw" class="external text external">"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis"</a>. <i>N Engl J Med</i>. <b>354</b> (8): 795–808. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2Fnejmoa052771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2Fnejmoa052771'" tppabs="https://doi.org/10.1056%2Fnejmoa052771" class="external text external">10.1056/nejmoa052771</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16495392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16495392'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16495392" class="external text external">16495392</a>.</cite></span></li><li id="cite_note-Sawitzke2010-23"> <span id="mw-reference-text-cite_note-Sawitzke2010-23" class="mw-reference-text"><cite id="CITEREFSawitzkeShiFincoDunlop2010" class="citation journal cs1">Sawitzke, Allen D.; Shi, Helen; Finco, Martha F.; Dunlop, Dorothy D.; Harris, Crystal L.; Singer, Nora G.; Bradley, John D.; Silver, David; Jackson, Christopher G.; Lane, Nancy E.; Oddis, Chester V.; Wolfe, Fred; Lisse, Jeffrey; Furst, Daniel E.; Bingham, Clifton O.; Reda, Domenic J.; Moskowitz, Roland W.; Williams, H. James; Clegg, Daniel O. (4 June 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604" class="external text external">"Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT"</a>. <i>Annals of the Rheumatic Diseases</i>. <b>69</b> (8): 1459–1464. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fard.2009.120469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fard.2009.120469'" tppabs="https://doi.org/10.1136%2Fard.2009.120469" class="external text external">10.1136/ard.2009.120469</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086604" class="external text external">3086604</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20525840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20525840'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20525840" class="external text external">20525840</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation journal cs1">Barnhill, JG; Fye, CL; Williams, DW; Reda, DJ; Harris, CL; Clegg, DO (2006). "Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial". <i>Journal of the American Pharmacists Association</i>. <b>46</b> (1): 14–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1331%2F154434506775268616  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1331%2F154434506775268616'" tppabs="https://doi.org/10.1331%2F154434506775268616" class="external text external">10.1331/154434506775268616</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16529337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16529337'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16529337" class="external text external">16529337</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite class="citation cs2"><a href="javascript:if(confirm('http://nccih.nih.gov/research/results/gait/qa.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://nccih.nih.gov/research/results/gait/qa.htm#b2'" tppabs="http://nccih.nih.gov/research/results/gait/qa.htm#b2" class="external text external">"Questions and Answers: NIH Glucosamine/Chondroitin Arthritis Intervention Trial Primary Study"</a>, <i>Backgrounder</i>, <span class="new">National Center for Complementary and Integrative Medicine</span>, 2006-01-02<span class="reference-accessdate">, retrieved <span class="nowrap">2013-10-17</span></span></cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text">Vergés J, Castañeda-Hernández, G. On the bioavailability of oral chondroitin sulfate formulations: proposed criteria for bioequivalence studies. Proc. West. Pharmacol. Soc., 2004; 47: 50-53</span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFAdebowale_AO_Cox_DSLiangEddington2000" class="citation journal cs1">Adebowale AO Cox DS, Liang Z, Eddington ND (2000). <a href="javascript:if(confirm('https://web.archive.org/web/20060407052246/http://www.americanutra.com/itemdetail.cfm?ProductID=37  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060407052246/http://www.americanutra.com/itemdetail.cfm?ProductID=37'" tppabs="https://web.archive.org/web/20060407052246/http://www.americanutra.com/itemdetail.cfm?ProductID=37" class="external text external">"Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials"</a>. <i>J Am Nutr Assoc</i>. <b>3</b>: 37–44. Archived from <a href="javascript:if(confirm('http://www.americanutra.com/itemdetail.cfm?ProductID=37  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.americanutra.com/itemdetail.cfm?ProductID=37'" tppabs="http://www.americanutra.com/itemdetail.cfm?ProductID=37" class="external text external">the original</a> on April 7, 2006.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFBhathalSpryszakLouizosFrankel2017" class="citation journal cs1">Bhathal, A; Spryszak, M; Louizos, C; Frankel, G (2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289" class="external text external">"Glucosamine and chondroitin use in canines for osteoarthritis: A review"</a>. <i>Open Veterinary Journal</i>. <b>7</b> (1): 36–49. doi:<a href="javascript:if(confirm('https://doi.org/10.4314%2Fovj.v7i1.6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4314%2Fovj.v7i1.6'" tppabs="https://doi.org/10.4314%2Fovj.v7i1.6" class="external text external">10.4314/ovj.v7i1.6</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356289" class="external text external">5356289</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28331832  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28331832'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28331832" class="external text external">28331832</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFBennettZainal_AriffinJohnston2012" class="citation journal cs1">Bennett, D; Zainal Ariffin, SM; Johnston, P (January 2012). "Osteoarthritis in the cat: 2. how should it be managed and treated?". <i>Journal of Feline Medicine and Surgery</i>. <b>14</b> (1): 76–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1098612X11432829  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1098612X11432829'" tppabs="https://doi.org/10.1177%2F1098612X11432829" class="external text external">10.1177/1098612X11432829</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22247327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22247327'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22247327" class="external text external">22247327</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFGoodrichNixon2006" class="citation journal cs1">Goodrich, LR; Nixon, AJ (January 2006). "Medical treatment of osteoarthritis in the horse - a review". <i>Veterinary Journal (London, England<span>&nbsp;</span>: 1997)</i>. <b>171</b> (1): 51–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tvjl.2004.07.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tvjl.2004.07.008'" tppabs="https://doi.org/10.1016%2Fj.tvjl.2004.07.008" class="external text external">10.1016/j.tvjl.2004.07.008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16427582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16427582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16427582" class="external text external">16427582</a>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://web.archive.org/web/20061105140135/http://www.arthritis.org/conditions/alttherapies/Glucosamine.asp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061105140135/http://www.arthritis.org/conditions/alttherapies/Glucosamine.asp'" tppabs="https://web.archive.org/web/20061105140135/http://www.arthritis.org/conditions/alttherapies/Glucosamine.asp" class="external text external">General Glucosamine and Chondroitin Sulfate information</a> at Arthritis Foundation</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20080820150410/http://www.consumerlabs.com/results/gluco.asp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080820150410/http://www.consumerlabs.com/results/gluco.asp'" tppabs="https://web.archive.org/web/20080820150410/http://www.consumerlabs.com/results/gluco.asp" class="external text external">"Product Review: Joint Supplements (Glucosamine, Chondroitin, and MSM)"</a> Summary of a Consumer Labs test of the actual composition of these supplements at consumerlabs.com</li>
<li><a href="javascript:if(confirm('http://www.webmd.com/content/article/22/1728_56163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.webmd.com/content/article/22/1728_56163'" tppabs="http://www.webmd.com/content/article/22/1728_56163" class="external text external">"Glucosamine/Chondroitin Products Not Measuring Up"</a>, News report of the analysis of commercial supplements by Adebowale et al. at WebMD</li>
<li><a href="javascript:if(confirm('http://www.stoneclinic.com/chondroitin_extraction.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.stoneclinic.com/chondroitin_extraction.htm'" tppabs="http://www.stoneclinic.com/chondroitin_extraction.htm" class="external text external">"Chondroitin Sulfate Manufacturing and Risk of Mad Cow Disease"</a> by Winston Wicomb, Ph.D., September 24, 2002.  Information on methods for extraction of chondroitin sulfate from cow trachea, at the Stone Clinic of San Francisco, at stoneclinic.com</li>
<li><a href="javascript:if(confirm('https://ntp.niehs.nih.gov/go/ts-09029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ntp.niehs.nih.gov/go/ts-09029'" tppabs="https://ntp.niehs.nih.gov/go/ts-09029" class="external text external">"Testing Status of Glucosamine Hydrochloride + Chondroitin Sulfate 09029"</a>, A thorough review of available information on the use of chondroitin sulfate in humans from the National Toxicology Program at National Institute of Environmental Health Sciences</li>
<li><a href="javascript:if(confirm('http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/cho_0071.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/cho_0071.shtml'" tppabs="http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/cho_0071.shtml" class="external text external">Chondroitin Sulfate</a>, summary of information on the use of chondroitin sulfate from the publishers of the <i>Physicians' Desk Reference</i>.</li>
<li>"<a href="javascript:if(confirm('http://www.clinicaltrials.gov/show/NCT00032890  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.clinicaltrials.gov/show/NCT00032890'" tppabs="http://www.clinicaltrials.gov/show/NCT00032890" class="external text external">Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)</a>," ClinicalTrials.gov information on the purpose, design, and analysis of the study at clinicaltrials.gov</li>
<li><a href="javascript:if(confirm('http://www.nih.gov/news/pr/feb2006/nccih-22.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nih.gov/news/pr/feb2006/nccih-22.htm'" tppabs="http://www.nih.gov/news/pr/feb2006/nccih-22.htm" class="external text external">"NIH News: Efficacy of Glucosamine and Chondroitin Sulfate May Depend on Level of Osteoarthritis Pain"</a>, Wednesday, February 22, 2006 at National Institutes of Health</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Dietary_supplements" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Dietary_supplements" style="font-size:114%;margin:0 4em">Dietary supplements</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Types</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Amino acids</li>
<li>Bodybuilding supplement</li>
<li>Energy drink</li>
<li>Energy bar</li>
<li>Fatty acids</li>
<li>Herbal supplements</li>
<li>Minerals</li>
<li>Prebiotics</li>
<li>Probiotics (Lactobacillus</li>
<li>Bifidobacterium)</li>
<li>Protein bar</li>
<li>Vitamins</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vitamins and<br>chemical elements<br> ("minerals")</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Vitamin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_A" title="Vitamin A">Retinol (Vitamin A)</a></li>
<li>B vitamins
<ul><li><a href="Thiamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamine" title="Thiamine">Thiamine (B<sub>1</sub>)</a></li>
<li><a href="Riboflavin.htm" tppabs="https://ptable.com/wiki/compounds/A/Riboflavin" title="Riboflavin">Riboflavin (B<sub>2</sub>)</a></li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin (B<sub>3</sub>)</a></li>
<li><a href="Pantothenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Pantothenic_acid" title="Pantothenic acid">Pantothenic acid (B<sub>5</sub>)</a></li>
<li>Pyridoxine (B<sub>6</sub>)</li>
<li><a href="Biotin.htm" tppabs="https://ptable.com/wiki/compounds/A/Biotin" title="Biotin">Biotin (B<sub>7</sub>)</a></li>
<li>Folic acid (B<sub>9</sub>)</li>
<li><a href="Cyanocobalamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyanocobalamin" title="Cyanocobalamin">Cyanocobalamin (B<sub>12</sub>)</a></li></ul></li>
<li><a href="Vitamin_C.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_C" title="Vitamin C">Ascorbic acid (Vitamin C)</a></li>
<li><a href="Vitamin_D.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_D" title="Vitamin D">Ergocalciferol and Cholecalciferol (Vitamin D)</a></li>
<li><a href="Vitamin_E.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_E" title="Vitamin E">Tocopherol (Vitamin E)</a></li>
<li><a href="Vitamin_K.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_K" title="Vitamin K">Naphthoquinone (Vitamin K)</a></li></ul>

<ul><li><a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">Calcium</a></li>
<li><a href="Choline.htm" tppabs="https://ptable.com/wiki/compounds/A/Choline" title="Choline">Choline</a></li>
<li><a href="Chromium.htm" tppabs="https://ptable.com/wiki/compounds/A/Chromium" title="Chromium">Chromium</a></li>
<li><a href="Cobalt.htm" tppabs="https://ptable.com/wiki/compounds/A/Cobalt" title="Cobalt">Cobalt</a></li>
<li><a href="Copper.htm" tppabs="https://ptable.com/wiki/compounds/A/Copper" title="Copper">Copper</a></li>
<li><a href="Fluorine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorine" title="Fluorine">Fluorine</a></li>
<li><a href="Iodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Iodine" title="Iodine">Iodine</a></li>
<li><a href="Iron.htm" tppabs="https://ptable.com/wiki/compounds/A/Iron" title="Iron">Iron</a></li>
<li><a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">Magnesium</a></li>
<li><a href="Manganese.htm" tppabs="https://ptable.com/wiki/compounds/A/Manganese" title="Manganese">Manganese</a></li>
<li><a href="Molybdenum.htm" tppabs="https://ptable.com/wiki/compounds/A/Molybdenum" title="Molybdenum">Molybdenum</a></li>
<li>Phosphorus</li>
<li><a href="Potassium.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium" title="Potassium">Potassium</a></li>
<li>Selenium</li>
<li><a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">Sodium</a></li>
<li><a href="Sulfur.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfur" title="Sulfur">Sulfur</a></li>
<li><a href="Zinc.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc" title="Zinc">Zinc</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other common <br>ingredients</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AAKG</li>
<li>β-hydroxy β-methylbutyrate</li>
<li><a href="Carnitine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carnitine" title="Carnitine">Carnitine</a></li>
<li><a href="Chondroitin_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Chondroitin_sulfate" title="Chondroitin sulfate">Chondroitin sulfate</a></li>
<li>Cod liver oil</li>
<li><a href="Copper_gluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Copper_gluconate" title="Copper gluconate">Copper gluconate</a></li>
<li><a href="Creatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatine" title="Creatine">Creatine</a></li>
<li>Dietary fiber</li>
<li>Echinacea</li>
<li>Elemental calcium</li>
<li><a href="Ephedra.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedra" title="Ephedra">Ephedra</a></li>
<li><a href="Fish_oil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fish_oil" title="Fish oil">Fish oil</a></li>
<li>Folic acid</li>
<li>Ginseng</li>
<li><a href="Glucosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucosamine" title="Glucosamine">Glucosamine</a></li>
<li><a href="Glutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutamine" title="Glutamine">Glutamine</a></li>
<li>Grape seed extract</li>
<li>Guarana</li>
<li><a href="Iron_supplement.htm" tppabs="https://ptable.com/wiki/compounds/A/Iron_supplement" title="Iron supplement">Iron supplements</a></li>
<li>Japanese honeysuckle</li>
<li>Krill oil</li>
<li>Lingzhi</li>
<li>Linseed oil</li>
<li><a href="Lipoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Lipoic_acid" title="Lipoic acid">Lipoic acid</a></li>
<li>Milk thistle</li>
<li><a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li>
<li>Red yeast rice</li>
<li>Royal jelly</li>
<li>Saw palmetto</li>
<li>Spirulina</li>
<li>St John's wort</li>
<li><a href="Taurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Taurine" title="Taurine">Taurine</a></li>
<li>Wheatgrass</li>
<li>Wolfberry</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li>
<li>Zinc gluconate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Related articles</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Codex Alimentarius</li>
<li>Enzyte</li>
<li>Hadacol</li>
<li>Herbal tea</li>
<li>Nutraceutical</li>
<li>Multivitamin</li>
<li>Nutrition</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Polysaccharides:_glycosaminoglycans" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:LightGray"><div id="Polysaccharides:_glycosaminoglycans" style="font-size:114%;margin:0 4em">Polysaccharides: glycosaminoglycans</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;background-color: LightGray">Unsulfated, extracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Hyaluronan.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyaluronan" title="Hyaluronan" class="mw-redirect">Hyaluronan</a></li>
<li><a href="Sodium_hyaluronate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_hyaluronate" title="Sodium hyaluronate">Sodium hyaluronate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background-color: LightGray">Sulfated, extracellular</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Chondroitin
<ul><li><a href="Chondroitin_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Chondroitin_sulfate" title="Chondroitin sulfate">Chondroitin sulfate</a></li>
<li><a href="Dermatan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dermatan_sulfate" title="Dermatan sulfate">Dermatan sulfate</a></li></ul></li>
<li><a href="Heparan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparan_sulfate" title="Heparan sulfate">Heparan sulfate</a></li>
<li>Keratan sulfate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background-color: LightGray">Sulfated, intracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">Heparin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background-color: LightGray">Synthetic</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Polysulfated glycosaminoglycan</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)_(primarily_M01A_and_M02A,_also_N02BA)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)_(primarily_M01A_and_M02A,_also_N02BA)" style="font-size:114%;margin:0 4em">Nonsteroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrazolones / <br><a href="Pyrazolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrazolidine" title="Pyrazolidine">Pyrazolidines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aminophenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminophenazone" title="Aminophenazone">Aminophenazone</a></li>
<li><a href="Ampyrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ampyrone" title="Ampyrone">Ampyrone</a></li>
<li>Azapropazone</li>
<li>Clofezone</li>
<li>Difenamizole</li>
<li>Famprofazone</li>
<li>Feprazone</li>
<li>Kebuzone</li>
<li><a href="Metamizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metamizole" title="Metamizole">Metamizole</a></li>
<li>Mofebutazone</li>
<li>Morazone</li>
<li><a href="Nifenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifenazone" title="Nifenazone">Nifenazone</a></li>
<li><a href="Oxyphenbutazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxyphenbutazone" title="Oxyphenbutazone">Oxyphenbutazone</a></li>
<li><a href="Phenazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenazone" title="Phenazone">Phenazone</a></li>
<li><b><a href="Phenylbutazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylbutazone" title="Phenylbutazone">Phenylbutazone</a></b></li>
<li>Propyphenazone</li>
<li><a href="Sulfinpyrazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfinpyrazone" title="Sulfinpyrazone">Sulfinpyrazone</a></li>
<li><a href="Suxibuzone.htm" tppabs="https://ptable.com/wiki/compounds/A/Suxibuzone" title="Suxibuzone">Suxibuzone</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylates</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Aspirin (acetylsalicylic acid)</a></b><sup>#</sup></li>
<li>Aloxiprin</li>
<li>Benorylate</li>
<li>Carbasalate calcium</li>
<li><a href="Diflunisal.htm" tppabs="https://ptable.com/wiki/compounds/A/Diflunisal" title="Diflunisal">Diflunisal</a></li>
<li>Dipyrocetyl</li>
<li><a href="Ethenzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethenzamide" title="Ethenzamide">Ethenzamide</a></li>
<li>Guacetisal</li>
<li>Magnesium salicylate</li>
<li><a href="Methyl_salicylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_salicylate" title="Methyl salicylate">Methyl salicylate</a></li>
<li><a href="Salsalate.htm" tppabs="https://ptable.com/wiki/compounds/A/Salsalate" title="Salsalate">Salsalate</a></li>
<li><a href="Salicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicin" title="Salicin">Salicin</a></li>
<li><a href="Salicylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylamide" title="Salicylamide">Salicylamide</a></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">Salicylic acid (salicylate)</a></li>
<li><a href="Sodium_salicylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_salicylate" title="Sodium salicylate">Sodium salicylate</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Acetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetic_acid" title="Acetic acid">Acetic acid</a> derivatives<br>and related substances</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aceclofenac</li>
<li><a href="Acemetacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Acemetacin" title="Acemetacin">Acemetacin</a></li>
<li>Alclofenac</li>
<li>Amfenac</li>
<li>Bendazac</li>
<li><a href="Bromfenac.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromfenac" title="Bromfenac">Bromfenac</a></li>
<li>Bumadizone</li>
<li><a href="Bufexamac.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufexamac" title="Bufexamac">Bufexamac</a></li>
<li><b><a href="Diclofenac.htm" tppabs="https://ptable.com/wiki/compounds/A/Diclofenac" title="Diclofenac">Diclofenac</a></b></li>
<li>Difenpiramide</li>
<li><a href="Etodolac.htm" tppabs="https://ptable.com/wiki/compounds/A/Etodolac" title="Etodolac">Etodolac</a></li>
<li><a href="Felbinac.htm" tppabs="https://ptable.com/wiki/compounds/A/Felbinac" title="Felbinac">Felbinac</a></li>
<li>Fenclozic acid</li>
<li>Fentiazac</li>
<li><a href="Indometacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Indometacin" title="Indometacin">Indometacin</a></li>
<li>Indometacin farnesil</li>
<li><span class="new">Isoxepac</span></li>
<li><a href="Ketorolac.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketorolac" title="Ketorolac">Ketorolac</a></li>
<li>Lonazolac</li>
<li>Oxametacin</li>
<li><span class="new">Prodolic acid</span></li>
<li>Proglumetacin</li>
<li><a href="Sulindac.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulindac" title="Sulindac">Sulindac</a></li>
<li><span class="new">Tiopinac</span></li>
<li><a href="Tolmetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolmetin" title="Tolmetin">Tolmetin</a></li>
<li><a href="Zomepirac.htm" tppabs="https://ptable.com/wiki/compounds/A/Zomepirac" title="Zomepirac">Zomepirac</a><sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oxicams</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Ampiroxicam</li>
<li>Droxicam</li>
<li>Isoxicam</li>
<li>Lornoxicam</li>
<li><a href="Meloxicam.htm" tppabs="https://ptable.com/wiki/compounds/A/Meloxicam" title="Meloxicam">Meloxicam</a></li>
<li><b><a href="Piroxicam.htm" tppabs="https://ptable.com/wiki/compounds/A/Piroxicam" title="Piroxicam">Piroxicam</a></b></li>
<li><a href="Tenoxicam.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenoxicam" title="Tenoxicam">Tenoxicam</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Propionic acid derivatives<br>(profens)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alminoprofen</li>
<li><a href="Benoxaprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Benoxaprofen" title="Benoxaprofen">Benoxaprofen</a><sup>†</sup></li>
<li><a href="Carprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Carprofen" title="Carprofen">Carprofen</a><sup>‡</sup></li>
<li>Dexibuprofen</li>
<li>Dexketoprofen</li>
<li><a href="Fenbufen.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenbufen" title="Fenbufen">Fenbufen</a></li>
<li><a href="Fenoprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenoprofen" title="Fenoprofen">Fenoprofen</a></li>
<li>Flunoxaprofen</li>
<li><a href="Flurbiprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Flurbiprofen" title="Flurbiprofen">Flurbiprofen</a></li>
<li><b><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a></b><sup>#</sup></li>
<li>Ibuproxam</li>
<li><a href="Indoprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Indoprofen" title="Indoprofen">Indoprofen</a><sup>†</sup></li>
<li><a href="Ketoprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoprofen" title="Ketoprofen">Ketoprofen</a></li>
<li>Loxoprofen</li>
<li>Miroprofen</li>
<li><b><a href="Naproxen.htm" tppabs="https://ptable.com/wiki/compounds/A/Naproxen" title="Naproxen">Naproxen</a></b></li>
<li><a href="Oxaprozin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaprozin" title="Oxaprozin">Oxaprozin</a></li>
<li>Pirprofen</li>
<li><a href="Suprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Suprofen" title="Suprofen">Suprofen</a></li>
<li>Tarenflurbil</li>
<li>Tepoxalin<sup>‡</sup></li>
<li><a href="Tiaprofenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiaprofenic_acid" title="Tiaprofenic acid">Tiaprofenic acid</a></li>
<li>Vedaprofen<sup>‡</sup></li>
<li>Zaltoprofen</li>
<li><i>COX-inhibiting nitric oxide donator</i>: Naproxcinod</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>N</i>-Arylanthranilic acids<br>(<a href="Fenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenamate" title="Fenamate" class="mw-redirect">fenamates</a>)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Azapropazone</li>
<li>Clonixin</li>
<li>Etofenamate</li>
<li><a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Flunixin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flunixin" title="Flunixin">Flunixin</a></li>
<li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><b><a href="Mefenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefenamic_acid" title="Mefenamic acid">Mefenamic acid</a></b></li>
<li>Morniflumate</li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><a href="Tolfenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li>
<li><span class="new">Flutiazin</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Coxibs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Apricoxib</li>
<li><b><a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">Celecoxib</a></b></li>
<li>Cimicoxib<sup>‡</sup></li>
<li>Deracoxib<sup>‡</sup></li>
<li><a href="Etoricoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoricoxib" title="Etoricoxib">Etoricoxib</a></li>
<li>Firocoxib<sup>‡</sup></li>
<li><a href="Lumiracoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Lumiracoxib" title="Lumiracoxib">Lumiracoxib</a><sup>†</sup></li>
<li>Mavacoxib<sup>‡</sup></li>
<li>Parecoxib</li>
<li>Robenacoxib<sup>‡</sup></li>
<li><a href="Rofecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Rofecoxib" title="Rofecoxib">Rofecoxib</a><sup>†</sup></li>
<li><a href="Valdecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Valdecoxib" title="Valdecoxib">Valdecoxib</a><sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aminopropionitrile.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminopropionitrile" title="Aminopropionitrile">Aminopropionitrile</a></li>
<li>Benzydamine</li>
<li><a href="Chondroitin_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Chondroitin_sulfate" title="Chondroitin sulfate">Chondroitin sulfate</a></li>
<li><a href="Diacerein.htm" tppabs="https://ptable.com/wiki/compounds/A/Diacerein" title="Diacerein">Diacerein</a></li>
<li>Fluproquazone</li>
<li><a href="Glucosamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucosamine" title="Glucosamine">Glucosamine</a></li>
<li>Glycosaminoglycan</li>
<li><a href="Hyperforin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><a href="Nabumetone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nabumetone" title="Nabumetone">Nabumetone</a></li>
<li><a href="Nimesulide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimesulide" title="Nimesulide">Nimesulide</a></li>
<li><a href="Oxaceprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li>
<li>Proquazone</li>
<li>Superoxide dismutase/Orgotein</li>
<li>Tenidap</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em">Items listed in <b>bold</b> indicate initially developed compounds of specific groups. <sup>#</sup>WHO-EM <sup>†</sup>Withdrawn drugs. <sup>‡</sup>Veterinary use medications.</div></td></tr></tbody></table></div>

<meta property="mw:PageProp/categorydefaultsort" content="Chondroitin Sulfate">

<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-20" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Chondroitin_sulfate&oldid=968655980  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Chondroitin_sulfate&oldid=968655980'" tppabs="https://en.wikipedia.org/wiki/?title=Chondroitin_sulfate&oldid=968655980">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>